DEVELOPMENT OF RODENT MODELS FOR XENOTRANSPLANTATION

Information

  • Research Project
  • 2751035
  • ApplicationId
    2751035
  • Core Project Number
    R01RR012186
  • Full Project Number
    5R01RR012186-02
  • Serial Number
    12186
  • FOA Number
  • Sub Project Id
  • Project Start Date
    8/1/1997 - 27 years ago
  • Project End Date
    9/30/1998 - 26 years ago
  • Program Officer Name
  • Budget Start Date
    8/1/1998 - 26 years ago
  • Budget End Date
    9/30/1998 - 26 years ago
  • Fiscal Year
    1998
  • Support Year
    2
  • Suffix
  • Award Notice Date
    6/30/1999 - 25 years ago

DEVELOPMENT OF RODENT MODELS FOR XENOTRANSPLANTATION

This research project is designed to develop relevant, cost effective rodent models for human xenotransplantation. The work outlined in the present proposal is designed to: (1) exchange cardiac xenografts between selected groups of donor/recipient species combinations and establish the immunopathologic characteristics of the type of xenograft reaction observed; (2) establish the nature of the immunoglobulin genes and B cell subsets that control the humoral response to xenografts and whether this response is consistent for different donor species; (3) compare the pattern of rejection for cardiac, liver, kidney, and pancreatic islet xenografts in a single door/recipient species combination, and (4) use rat monoclonal antibodies to isolate and characterize xenograft target antigens, first in hamster and later in related species, to establish the most appropriate species combination for providing the basis for similar experiments in species that may serve as potential xenograft donors for humans. The information derived from these studies will be important for defining which species of small animals can be considered to represent the best models for human pig and/or primate xenografting. The definition of the most appropriate rodent model for human xenotransplantation has the potential for wide use by investigators in many areas of medical research, especially those in which the use of tissues from non-human donors are used as a part of new treatment strategies for diseases such as diabetes, neurological disorders, cardiovascular disease and specific gene therapies.

IC Name
NATIONAL CENTER FOR RESEARCH RESOURCES
  • Activity
    R01
  • Administering IC
    RR
  • Application Type
    5
  • Direct Cost Amount
  • Indirect Cost Amount
  • Total Cost
  • Sub Project Total Cost
  • ARRA Funded
  • CFDA Code
    306
  • Ed Inst. Type
  • Funding ICs
  • Funding Mechanism
  • Study Section
    RIRG
  • Study Section Name
    National Center for Research Resources Initial Review Group
  • Organization Name
    ST. VINCENT MEDICAL CENTER
  • Organization Department
  • Organization DUNS
  • Organization City
    LOS ANGELES
  • Organization State
    CA
  • Organization Country
    UNITED STATES
  • Organization Zip Code
    900570992
  • Organization District
    UNITED STATES